Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

N-((4-cyano-2-(trifluoromethyl)phenyl)methyl)-3-((4-methyl-6-(methylamino)-1,3,5-triazin-2-yl)amino)cyclohexanecarboxamide MeSH Supplementary Concept Data 2026


MeSH Supplementary
N-((4-cyano-2-(trifluoromethyl)phenyl)methyl)-3-((4-methyl-6-(methylamino)-1,3,5-triazin-2-yl)amino)cyclohexanecarboxamide
Unique ID
C584201
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C584201
Entry Term(s)
GSK2256294
Registry Numbers
0
Heading Mapped to
*Cyclohexylamines
*Triazines
Frequency
11
Note
inhibits soluble epoxide hydrolase; structure in first source
Source
J Cardiovasc Pharmacol. 2013 Apr;61(4):291-301.
Date Introduced
2013/11/05
Last Updated
2013/11/05
N-((4-cyano-2-(trifluoromethyl)phenyl)methyl)-3-((4-methyl-6-(methylamino)-1,3,5-triazin-2-yl)amino)cyclohexanecarboxamide Preferred
GSK2256294 Narrower
page delivered in 0.005s